1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Spectral Changes of EEG Following a 6-Week Low-Dose Oral Ketamine Treatment in Adults With Major Depressive Disorder and Chronic Suicidality
(
- Contribution to journal › Article
- 2022
-
Mark
Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: : A Randomized, Open-Label, Non-Inferiority Trial (KetECT)
(
- Contribution to journal › Article
- 2018
-
Mark
Macrophage Migration Inhibitory Factor and microRNA-451a in Response to Mindfulness-based Therapy or Treatment as Usual in Patients with Depression, Anxiety, or Stress and Adjustment Disorders
(
- Contribution to journal › Article
- 2016
-
Mark
Glutathione Deficit Affects the Integrity and Function of the Fimbria/Fornix and Anterior Commissure in Mice : Relevance for Schizophrenia
(
- Contribution to journal › Article
- 2015
-
Mark
Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease
(
- Contribution to journal › Article
- 2008
-
Mark
Hippocampal cytogenesis is increased in FSL strain, a genetic rat model of depression. Escitalopram reduces increased cell number
2008) XXVI CINP Congress In International Journal of Neuropsychopharmacology 11(Supplement S1). p.124-125(
- Contribution to journal › Published meeting abstract
-
Mark
Effect of stimulus parameters in a rat model of electroconvulsive seizures
2008) XXVI CINP Congress In International Journal of Neuropsychopharmacology 11(Supplement S1). p.119-119(
- Contribution to journal › Published meeting abstract
-
Mark
Role of neuroticism and neurochemical changes in suicidal behaviour
2008) XXVI CINP Congress In International Journal of Neuropsychopharmacology 11(Supplement S1). p.132-132(
- Contribution to journal › Published meeting abstract
-
Mark
Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days
(
- Contribution to journal › Article
- 2006
-
Mark
The effects of celecoxib augmentation on cytokine levels in schizophrenia
(
- Contribution to journal › Article